Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02596932 · ClinicalTrials.gov registry record · NA
Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT02596932 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 76 participants.
The verdict
NCT02596932, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
Gestational Diabetes Mellitus (GDM) is one of the most common medical complications of pregnancy. Neonatal hypoglycemia is a common and well described complication for infants born to mothers with GDM and diabetes mellitus (DM) and studies have linked intrapartum maternal glucose levels with neonatal hypoglycemia. While guidelines exist to guide practitioners in how to best manage intrapartum maternal glucose levels among Type I and and Type II DM, there is a paucity of data guiding practitioners in the intrapartum management of blood glucose levels for women with GDM, particularly those treated with insulin antepartum. The goal of this project is to compare two protocols of intrapartum glucose management in women with GDM and investigate the impact on neonatal blood glucose levels.
Interventions
- OTHER Standard Protocol for intrapartum glucose management
- OTHER Experimental Protocol for intrapartum glucose management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02596932
The ClinicalTrials.gov registry entry for NCT02596932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Protocol for intrapartum glucose management is the first listed.
NCT02596932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02596932 about?
NCT02596932 is a clinical study titled "Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus". Gestational Diabetes Mellitus (GDM) is one of the most common medical complications of pregnancy. Neonatal hypoglycemia is a common and well described complication for infants born to mothers with GDM and diabetes mellitus (DM) and studies have linked intrapartum maternal glucose levels with neonata...
What is the current status of trial NCT02596932?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2016-02. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02596932?
The interventions under investigation include: Standard Protocol for intrapartum glucose management (OTHER), Experimental Protocol for intrapartum glucose management (OTHER).
Who is sponsoring clinical trial NCT02596932?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.